With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

Pfizer CEO is set to meet with activist investor Starboard Value after the investor acquired a $1 billion stake in the ...

As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Pfizer (PFE), which became a household name during the pandemic with its COVID-19 vaccine, has since been struggling. PFE has ...

Pfizer (PFE) discontinues development of experimental RSV therapy sisunatovir from pipeline in a blow for its $525M ...

PFE obtains $1 billion from activist investor Starboard Value. Stock gains on hopes of a plausible turnaround of the ...

While Pfizer has made a number of acquisitions, its biggest bet is on Seagen. Pfizer wants this to be a transformative ...

Scholar Rock yesterday reported that its experimental treatment for spinal muscular atrophy succeeded in a Phase 3 trial, ...

The S&P 500 rose to a record high, as investors pushed Wall Street’s benchmark index higher ahead of important reports and data that could shed light on the Federal Reserve’s next interest rate ...

The first major outbreak of spring thunderstorms is firing up this week across parts of Queensland and New South Wales, bringing with them threats of the destructive supercell storm. As national ...

Solara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 3,642.07 Crore) operating in Pharmaceuticals sector. Solara Active Pharma Sciences ...